24
Participants
Start Date
June 29, 2013
Primary Completion Date
July 8, 2013
Study Completion Date
October 25, 2013
Klaribact 125mg/5ml Suspension
one single 20 mL dose (500mg) of the test drug will be administered to the volunteers
Klaricid 125mg/5ml Suspension
one single 20 mL dose (500mg) of the Reference drug will be administered to the volunteers
Center for Bioequivalence Studies and clinical research (CBSCR), ICCBS, Karachi
Merck (Pvt.) Limited, Pakistan
UNKNOWN
Center for Bioequivalence Studies and Clinical Research (CBSCR), HEJ Research Institute of chemistry, University of Karachi
UNKNOWN
University of Karachi
OTHER